Skip to content
  • Home
  • Book Bag: 0 items (Full)
    • English
    • 日本語
    • 中文(简体)
    • 中文(繁體)
    • اللغة العربية
  • About
Advanced
  • 579 Evaluation of cemiplimab t...
  • Cite this
  • Text this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Add to Book Bag Remove from Book Bag
  • Permanent link

579 Evaluation of cemiplimab treatment duration: clinical outcomes in advanced CSCC

Bibliographic Details
Published in:Journal for ImmunoTherapy of Cancer
Main Authors: Francesca Sparano, Corrado Caracò, Ester Simeone, Assunta Esposito, Lucia Festino, Alfredo Budillon, Domenico Mallardo, Vito Vanella, Paolo Ascierto, Claudia Trojaniello, Maria Grazia Vitale, Margaret Ottaviano, Mario Mallardo, Eleonora Cioli, Teresa De Cristofaro, Boanca Arianna Facchini, Paolo Meinardi
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
  • Holdings
  • Description
  • Similar Items
  • Staff View

Similar Items

  • 42 IL-6 as prognostic factor in adjuvant or metastatic skin cancer patients treated with immunotherapy – a deep biomarker analysis
    by: Francesca Sparano, et al.
    Published: (2023-11-01)
  • 1247 Gene signature predict autoimmune toxicity in patients with metastatic melanoma
    by: Michael Bailey, et al.
    Published: (2023-11-01)
  • Gene-expression signature predicts autoimmune toxicity in metastatic melanoma
    by: Michael Bailey, et al.
    Published: (2025-07-01)
  • Gene Signatures predict immune-related skin adverse events in melanoma patients
    by: D. Mallardo, et al.
    Published: (2024-01-01)
  • Real-world evidence study on the early use of cemiplimab in the UK: REACT-CEMI (Real World evidence of advanced CSCC treatment with cemiplimab)
    by: Amarnath Challapalli, et al.
    Published: (2024-07-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs